SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-22-001406
Filing Date
2022-10-31
Accepted
2022-10-31 15:16:31
Documents
56
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tlcc-20220930.htm   iXBRL 10-Q 1281847
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 12815
8 EXHIBIT 32.1 ex321_2.htm EX-32.1 6985
  Complete submission text file 0001753926-22-001406.txt   6205631

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20220930_def.xml EX-101.DEF 180067
3 PRESENTATION tlcc-20220930_pre.xml EX-101.PRE 320289
4 CALCULATION tlcc-20220930_cal.xml EX-101.CAL 63000
5 LABEL tlcc-20220930_lab.xml EX-101.LAB 550437
6 SCHEMA tlcc-20220930.xsd EX-101.SCH 43161
50 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20220930_htm.xml XML 1067138
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 221345583
SIC: 2833 Medicinal Chemicals & Botanical Products